Two courses on data quality to support MCM development for high-consequence pathogens

Register by March 7, 2019

Two courses on data quality to support MCM development for high-consequence pathogens

April 8-12, 2019 (Bethesda, MD) Achieving Data Quality and Integrity in Maximum Containment Laboratories  This popular course offers a unique opportunity for the regulatory and scientific communities to discuss complex issues in an interactive environment and identify and share best practices for ensuring nonclinical data quality and integrity in BSL-4 facilities. Register April 8-10, 2019 (Bethesda, MD) New course! Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens  New course focusing on the preparation and execution of research clinical trials to facilitate the approval of medical countermeasures for high-consequence pathogens. Register Both courses are hosted by FDA's Medical Countermeasures Initiative (MCMi) and the University of Texas Medical Branch at Galveston (UTMB).

Related information: MCMi Professional Development Activities